Project Grant R21AI200716
Award Date 6/1/26
Completion Date 5/31/28
Dollars Obligated $507K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- Award Summary The Wistar Institute of Anatomy and Biology received a $887,239 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective May 1, 2026, through April 30, 2031. This award funds research directed at addressing a critical barrier to HIV-1 vaccine development: the immunodominance of non-neutralizing antibody responses targeting the envelope glycoprotein base, which fails to provide...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $475,681 Project Grant to the University of Wisconsin–Madison under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period February 1, 2026, through January 31, 2031. The award supports the development and validation of novel molecular and cellular tools to investigate HIV-1 alternatively spliced transcript functionality. The primary deliverable is a suite of...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $489,500 to The Children's Hospital of Philadelphia Research Institute on June 11, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This two-year project, which extends through May 31, 2027, focuses on developing novel sequencing methodologies and analytical pipelines to identify and characterize intact human immunodeficiency virus (HIV) reservoir cells...
- Federal Grant Award Summary New York University School of Medicine received an $841,719 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2031. This research initiative focuses on developing and validating low-cost, rapid antibody-based tests to complement polymerase chain reaction (PCR) testing for monitoring HIV treatment...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $100,228 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period November 15, 2026 through May 31, 2029. This research project, titled "Mapping HIV Reservoir Establishment in Human Tonsil Organoids," focuses on understanding the cellular and viral characteristics of nonproductively...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $899,850 to the Whitehead Institute for Biomedical Research under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 20, 2026, for a project concluding January 31, 2031. This Project Grant funds investigator-initiated biomedical research aimed at elucidating the molecular mechanisms by which apicomplexan parasites recognize and invade host cells. The research will...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $368,750 to the Veterans Medical Research Foundation of San Diego under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 10, 2025, for a project period extending through June 30, 2030. This Project Grant funds biomedical research investigating the mechanisms by which HIV-1 and HIV-2 antagonize BST2/tetherin, an interferon-stimulated gene with potent antiviral...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant valued at $427,623 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for investigator-initiated biomedical research. The award, obligated on February 24, 2026, with a completion date of January 31, 2028, funds research investigating how HIV-induced immunometabolic perturbation impairs tuberculosis (TB) control in people living with...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $162,000 Project Grant to The Wistar Institute of Anatomy and Biology on February 5, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to define the single-cell epigenetic landscape of the human immunodeficiency virus type 1 (HIV-1) reservoir to enable more effective latency reversal strategies. The research addresses a critical gap in HIV cure research by...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $650,934 Project Grant to Washington University in St. Louis effective August 1, 2025, through July 31, 2027, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This award funds a mechanistic research study investigating how HIV-1 Gag/matrix proteins sequester the CARD8 inflammasome, a key immune pathway involved in detecting and responding to HIV-1 infection....